Polycystic liver disease, commonly associated with polycystic kidney disease, can result in massive hepatomegaly and debilitating symptoms. Surgical intervention for symptomatic polycystic liver disease has been associated with significant morbidity and inconsistent long-term palliation; it is more
Liver Transplantation in Adults
โ Scribed by David H. Van Thiel; Robert R. Schade; Thomas E. Starzl; Shunzaburo Iwatsuki; Byers W. ; Shaw Jr .; Judith S. Gavaler; Marcus Dugas
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 462 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
โฆ Synopsis
Human liver transplantation has been possible since 1967. We report our experience in 32 adult patients who received liver transplants at the University of Pittsburgh over a 16-month period. Survival data, method utilized for patient selection, costs, and morbidity of the procedure are discussed.
Orthotopic liver transplantation for humans with advanced liver disease has been possible since 1967 when the first extended survival of such a patient was reported. Since then, more than 400 procedures have been performed; the majority (360) were performed by two groups; one in London (Calne) and the other in the United States (Starzl). At the time of this writing, 237 orthotopic liver transplants have been performed by Starzl; 170 at the University of Colorado and 67 at the University of Pittsburgh. We report the results in adults at the University of Pittsburgh and discuss patient selection, morbidity, cost, and institutional commitment.
PATIENT SELECTION
From February 1, 1981 through May 30, 1982, 32 orthotopic liver transplants were performed in adults at the University of Pittsburgh School of Medicilie; the indications are shown in Table 1. The major indication, accounting for nearly one-third of the cases, was postnecrotic cirrhosis. The second and third most common indications for liver transplantation were advanced primary biliary cirrhosis and hepatocellular carcinoma respectively.
The 32 patients were selected from 115 individuals who were evaluated for liver transplantation. All were referred specifically for consideration for possible liver transplantation. Sixty-eight were considered acceptable candidates based upon the severity of liver disease and the absence of factors known to contradict transplantation.
The disease categories of the potential candidates is shown in Table 2. Of the 68 acceptable candidates, only one refused transplantation after having been accepted for this procedure.
๐ SIMILAR VOLUMES
Quality of life is an important factor to consider when assessing the value of liver transplantation. Using a large, prospective database of liver transplantation recipients from three clinical centers in the United States, we examined the quality of life of 346 adults before and 1 year after surger
To assess the efficacy of influenza vaccination in immunocompromised adult liver transplant (LTx) recipients, the serum antibody responses of 61 of these patients and 35 liver cirrhosis patients with those of 45 of their healthy spouses were compared, after one and two vaccinations with a commercial
Infectious complications such as bacteremia after living donor liver transplantation (LDLT) are associated with significant morbidity and mortality. We retrospectively analyzed the frequency and characteristics of posttransplant bacteremia in 181 adult LDLT recipients between April 2006 and November
The purpose of donor evaluation for adult-to-adult living donor liver transplantation (LDLT) is to discover medical conditions that could increase the donor postoperative risk of complications and to determine whether the donor can yield a suitable graft for the recipient. We report the outcomes of